Biote (BTMD) Preferred Stock Liabilities (2021 - 2022)
Biote (BTMD) posted quarterly Preferred Stock Liabilities of $317.5 million for Q1 2022, little changed year-over-year from $317.5 million in Q1 2021, and little changed on a QoQ basis from $317.5 million in Q4 2021.
Biote (BTMD) Preferred Stock Liabilities (2021 - 2022) Analysis & Trends
Biote (BTMD) has reported Preferred Stock Liabilities for 2 consecutive years, with $317.5 million the latest figure, recorded in Q1 2022.
- In Q1 2022, Preferred Stock Liabilities changed 0.0% year-over-year to $317.5 million; the TTM figure through Mar 2022 stood at $317.5 million (changed 0.0% YoY), while the FY2021 annual figure was $317.5 million, changed N/A from the prior year.
- Preferred Stock Liabilities came in at $317.5 million for Q1 2022 at Biote, roughly flat from $317.5 million in the prior quarter.
- The five-year high for Preferred Stock Liabilities was $317.5 million in Q2 2021, with the low at $317.5 million in Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 87.94 Bn | 90.32 Bn | 16.26 Bn | - |
| 2 | Chemed | 18.08 Bn | 18.07 Bn | 215.76 Mn | - |
| 3 | Tenet Healthcare | 16.59 Bn | 15.76 Bn | 4.41 Bn | - |
| 4 | Davita | 15.37 Bn | 16.23 Bn | 1.07 Bn | - |
| 5 | Encompass Health | 10.07 Bn | 10.70 Bn | 1.34 Bn | - |
| 6 | Ensign | 9.52 Bn | 8.93 Bn | 293.37 Mn | - |
| 7 | Universal Health Services | 9.19 Bn | 9.15 Bn | 3.21 Bn | - |
| 8 | Pacs | 6.96 Bn | 6.72 Bn | 345.96 Mn | - |
| 9 | Ww International | 6.14 Bn | 5.98 Bn | -149.29 Mn | - |
| 10 | Biote | 5,970.00 | 2.82 Mn | 30.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 317.50 Mn |
| Dec 31, 2021 | 317.50 Mn |
| Sep 30, 2021 | 317.50 Mn |
| Jun 30, 2021 | 317.50 Mn |
| Mar 31, 2021 | 317.50 Mn |